Inventor · disambiguated record
Laura Ann Mcallister
Also filed as: MCALLISTER LAURA · MCALLISTER LAURA ANN
16 granted patents·12 pending applications·18 citations·filing 2011–2025
88Inventor score
Top patents by PatentIndex Score
28 records- 0190US9845301B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2016·Granted Dec 19, 2017·8 cites·9 claims
- 0289US10604519B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2017·Granted Mar 31, 2020·3 cites·24 claims
- 0383US10329308B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2018·Granted Jun 25, 2019·2 cites·23 claims
- 0483US2024190869A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 0582US10428034B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2017·Granted Oct 1, 2019·3 cites·18 claims
- 0681US2023192690A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 0779US10858373B2Heterocyclic spiro compounds as MAGL inhibitorsPFIZER·Filed 2019·Granted Dec 8, 2020·1 cites·17 claims
- 0877US11905284B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2021·Granted Feb 20, 2024·0 cites·18 claims
- 0975US12398119B2Piperazine azaspiro derivativesPFIZER·Filed 2022·Granted Aug 26, 2025·0 cites·3 claims
- 1074US12257247B2Targeted degradation of VAV1MONTE ROSA THERAPEUTICS AG·Filed 2024·Granted Mar 25, 2025·0 cites·12 claims
- 1171US12391663B2Isoindolinone compoundsMONTE ROSA THERAPEUTICS AG·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 1268US12459920B2Targeted protein degradationMONTE ROSA THERAPEUTICS AG·Filed 2025·Granted Nov 4, 2025·0 cites·5 claims
- 1368US2025340528A1Targeted protein degradationMONTE ROSA THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 1468US2020207762A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2020·Application pending·0 cites
- 1567US8933095B2KAT II inhibitorsPFIZER·Filed 2013·Granted Jan 13, 2015·1 cites·20 claims
- 1666US10723711B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2019·Granted Jul 28, 2020·0 cites·18 claims
- 1763US10626125B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2019·Granted Apr 21, 2020·0 cites·23 claims
- 1860US2025115582A1Molecular glue degraders and methods of using the sameMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1960US2025171420A1Molecular glue degraders and methods of using the sameMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2060US2025115581A1Substituted piperidines as ck1a degradersMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2157US2024308976A1Compounds that mediate protein degradation and uses thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2256US2018208608A1Heterocyclic spiro compounds as magl inhibitorsPFIZER·Filed 2018·Application pending·0 cites
- 2352US11524954B2Piperazine azaspiro derivativesPFIZER·Filed 2019·Granted Dec 13, 2022·0 cites·30 claims
- 2452US2025205219A1Targeted degradation of vav1MONTE ROSA THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 2551US2025263395A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 2647US2021309669A1Heterocyclic Spiro Compounds As MAGL InhibitorsPFIZER·Filed 2019·Application pending·0 cites
- 2743US11198692B2Dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2018·Granted Dec 14, 2021·0 cites·21 claims
- 2840US8598200B2KAT II inhibitorsDOUNAY AMY B·Filed 2011·Granted Dec 3, 2013·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Laura Ann Mcallister files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →